Posts in category

In Depth


There was much anticipation for the pharmacists in aged care program, but delays have pushed back its commencement, and anger is growing about a seeming backflip over how the program …

With only a couple of weeks before it’s due to begin, Angelo Pricolo looks at the national ODT (Opioid Dependence Treatment) Community Pharmacy program… and wonders about the detail Sometimes …

Debbie Rigby takes a look at the latest in research news Pharmacist-led medication review in a residential in-reach service leads to deprescribing The introduction of a pharmacist-led medication review service …

Now is the time for pharmacies to develop their response strategy to 60-day dispensing. John Thornett suggests some tactics that should be considered  In the past, Community Pharmacy Agreements provided …

The community pharmacy sector has been shaken to its very core by the government announcing a move to 60-day dispensing for around 300 medicines. How did it come to this? …

June 1923: newly-discovered insulin was on its way, debate raged over the title “chemist” and newly outlawed cocaine was also under discussion in the AJP One of the key stories …

Here’s why expanding scope of practice for pharmacists would shrink the loneliness crisis, writes Jenny Kirschner Connection Matters is the theme for Loneliness Awareness Week this June 12-18th 2023.[1] Loneliness …

Debbie Rigby rounds up the latest in research news Approach to schizophrenia Schizophrenia is the most common of a group of psychotic disorders that occur in approximately 3% of the …

These are dark times for community pharmacy, but there may be a silver lining if you’re prepared to reach for it say Glenn Guilfoyle and Norman Thurecht Every dark cloud …

We spend around a third of our lives sleeping—or in some cases attempting to. Surely, this highlights just how crucial sleep is for long-term health, writes Leanne Philpott Sleep problems …

What’s life like as an onsite aged care pharmacist? This guest author has the answer… There was movement at the station, for the word had passed around… No, I’m not …

Debbie Rigby rounds up the latest in research news Comparative Effectiveness of Umeclidinium/Vilanterol versus Inhaled Corticosteroid/Long-Acting β2-Agonist in Patients with Chronic Obstructive Pulmonary Disease Among patients with COPD without exacerbations …